Medicare Enrolled

Dr. Delong Liu, M.D., PH.D.

Hematology · Hawthorne, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
19 BRADHURST AVE, Hawthorne, NY 10532
9144938375
In practice since 2006 (20 years)
NPI: 1538122932 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Liu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Liu

Dr. Delong Liu is a hematology specialist in Hawthorne, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Liu performed 1,179 Medicare services across 276 unique beneficiaries.

Between the years covered by Open Payments, Dr. Liu received a total of $515,737 from 33 pharmaceutical and/or device companies across 483 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Liu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 12% volume in NY $515,737 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,179
Medicare services
Top 12% in NY for hematology
276
Unique beneficiaries
$114
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~59 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
607 $110 $397
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
448 $116 $421
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
40 $108 $409
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
37 $158 $776
Biopsy of bone marrow 16 $156 $624
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
16 $80 $443
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
15 $154 $642
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$515,737
Total received (2018-2024)
Avg $73,677/year across 7 years
Top 4% in NY for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
483
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$418,192 (81.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$95,300 (18.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,246 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$88,687
2023
$88,188
2022
$77,710
2021
$49,952
2020
$32,518
2019
$124,139
2018
$54,543

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
BeiGene USA, Inc.
$37,118
Rigel Pharmaceuticals, Inc.
$25,125
Takeda Pharmaceuticals U.S.A., Inc.
$11,880
Astellas Pharma US Inc
$11,312
Novartis Pharmaceuticals Corporation
$2,700
AstraZeneca Pharmaceuticals LP
$400
Exelixis Inc.
$75
Kite Pharma, Inc.
$52
Incyte Corporation
$24
Top 3 companies account for 83.6% of 2024 payments
All-time payments by company (2018-2024) ›
BeiGene USA, Inc.
$165,117
Astellas Pharma US Inc
$85,986
Incyte Corporation
$80,514
Rigel Pharmaceuticals, Inc.
$62,604
Pharmacyclics LLC, An AbbVie Company
$30,876
AstraZeneca Pharmaceuticals LP
$16,403
Takeda Pharmaceuticals U.S.A., Inc.
$12,223
PharmaEssentia USA Corporation
$9,517
Janssen Biotech, Inc.
$8,198
GENZYME CORPORATION
$7,386
Jazz Pharmaceuticals Inc.
$5,452
NOVARTIS PHARMACEUTICALS CORPORATION
$4,840
E.R. Squibb & Sons, L.L.C.
$4,356
Celgene Corporation
$4,091
JAZZ PHARMACEUTICALS INC.
$4,045
Novartis Pharmaceuticals Corporation
$2,769
GlaxoSmithKline, LLC.
$2,600
PFIZER INC.
$2,405
TAIHO ONCOLOGY, INC.
$2,112
Helsinn Therapeutics (U.S.), Inc.
$1,845
BeiGene (Suzhou) Co., Ltd.
$1,268
Exelixis Inc.
$275
Amgen Inc.
$229
SERVIER PHARMACEUTICALS LLC
$140
Sirtex Medical Inc
$126
Eisai Inc.
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Kite Pharma, Inc.
$52
EMD Serono, Inc.
$41
EUSA Pharma (US) LLC
$23
KADMON PHARMACEUTICALS LLC
$22
Merck Sharp & Dohme Corporation
$17
ADC Therapeutics America, Inc.
$11
Top 3 companies account for 64.3% of all-time payments
Associated products mentioned in payments ›
BESREMI · BLENREP · BOSULIF · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · Cabometyx · DEFITELIO · ELITEK · EMPLICITI · Erleada · GILOTRIF · ICLUSIG · IMBRUVICA · IMFINZI · INQOVI · Imbruvica · JAKAFI · KEYTRUDA · KISQALI · LIVTENCITY · Lenvima · MAVENCLAD · MYLOTARG · OPDIVO · PROMACTA · Pomalyst · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · Sylvant · TAGRISSO · TASIGNA · Tavalisse · Tibsovo · VALCHLOR · VYXEOS · XGEVA · XOSPATA · Xospata · Yescarta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for hematology in NY.

Looking for a hematology specialist in Hawthorne?
Compare hematologists in the Hawthorne area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists within 10 mi
115
Per 100K population
11.5
County median income
$118,411
Nearest hospital
WESTCHESTER MEDICAL CENTER
1.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Liu is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NY), with speaking/promotional industry engagement in the top 4% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Liu experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Liu performed 607 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Liu receive payments from pharmaceutical companies?
Yes. Dr. Liu received a total of $515,737 from 33 companies across 483 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liu's costs compare to other hematologists in Hawthorne?
Dr. Liu's average Medicare payment per service is $114. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →